These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8892377)

  • 1. Novel receptor mechanisms for heroin and morphine-6 beta-glucuronide analgesia.
    Rossi GC; Brown GP; Leventhal L; Yang K; Pasternak GW
    Neurosci Lett; 1996 Sep; 216(1):1-4. PubMed ID: 8892377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential blockade of morphine and morphine-6 beta-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats.
    Rossi GC; Standifer KM; Pasternak GW
    Neurosci Lett; 1995 Sep; 198(2):99-102. PubMed ID: 8592651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1.
    Schuller AG; King MA; Zhang J; Bolan E; Pan YX; Morgan DJ; Chang A; Czick ME; Unterwald EM; Pasternak GW; Pintar JE
    Nat Neurosci; 1999 Feb; 2(2):151-6. PubMed ID: 10195199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No heroin or morphine 6beta-glucuronide analgesia in mu-opioid receptor knockout mice.
    Kitanaka N; Sora I; Kinsey S; Zeng Z; Uhl GR
    Eur J Pharmacol; 1998 Aug; 355(1):R1-3. PubMed ID: 9754945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of dihydromorphine, 6-acetyldihydromorphine and dihydroheroin analgesia and their differentiation from morphine.
    Gilbert AK; Hosztafi S; Mahurter L; Pasternak GW
    Eur J Pharmacol; 2004 May; 492(2-3):123-30. PubMed ID: 15178355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
    Rady JJ; Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6beta-glucuronide antinociception.
    Rossi GC; Leventhal L; Pan YX; Cole J; Su W; Bodnar RJ; Pasternak GW
    J Pharmacol Exp Ther; 1997 Apr; 281(1):109-14. PubMed ID: 9103486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute cross-tolerance to opioids in heroin delta-opioid-responding Swiss Webster mice.
    Rady JJ; Fujimoto JM
    J Biomed Sci; 2000; 7(3):258-69. PubMed ID: 10810246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C-mediated acute tolerance to peripheral mu-opioid analgesia in the bradykinin-nociception test in mice.
    Inoue M; Ueda H
    J Pharmacol Exp Ther; 2000 May; 293(2):662-9. PubMed ID: 10773042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6 beta-glucuronide receptor.
    Rossi GC; Pan YX; Brown GP; Pasternak GW
    FEBS Lett; 1995 Aug; 369(2-3):192-6. PubMed ID: 7649256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse.
    Vaught JL; Mathiasen JR; Raffa RB
    J Pharmacol Exp Ther; 1988 Apr; 245(1):13-6. PubMed ID: 2834533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist.
    Kolesnikov Y; Pasternak GW
    J Pharmacol Exp Ther; 1999 Jul; 290(1):247-52. PubMed ID: 10381783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T394A Mutation at the μ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice.
    Wang XF; Barbier E; Chiu YT; He Y; Zhan J; Bi GH; Zhang HY; Feng B; Liu-Chen LY; Wang JB; Xi ZX
    J Neurosci; 2016 Oct; 36(40):10392-10403. PubMed ID: 27707973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnitude of tolerance to fentanyl is independent of mu-opioid receptor density.
    Chan KW; Duttory A; Yoburn BC
    Eur J Pharmacol; 1997 Jan; 319(2-3):225-8. PubMed ID: 9042594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine-6beta-glucuronide-induced hyperphagia: characterization of opioid action by selective antagonists and antisense mapping in rats.
    Leventhal L; Silva RM; Rossi GC; Pasternak GW; Bodnar RJ
    J Pharmacol Exp Ther; 1998 Nov; 287(2):538-44. PubMed ID: 9808678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacology of mu analgesics: from patients to genes.
    Pasternak GW
    Neuroscientist; 2001 Jun; 7(3):220-31. PubMed ID: 11499401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice.
    Shen J; Benedict Gomes A; Gallagher A; Stafford K; Yoburn BC
    Synapse; 2000 Dec; 38(3):322-7. PubMed ID: 11020235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explanation at the opioid receptor level for differing toxicity of morphine and morphine 6-glucuronide.
    Hucks D; Thompson PI; McLoughlin L; Joel SP; Patel N; Grossman A; Rees LH; Slevin ML
    Br J Cancer; 1992 Jan; 65(1):122-6. PubMed ID: 1310249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional blockade of opioid analgesia by orphanin FQ/nociceptin.
    King M; Chang A; Pasternak GW
    Biochem Pharmacol; 1998 May; 55(9):1537-40. PubMed ID: 10076548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes.
    Bolan EA; Tallarida RJ; Pasternak GW
    J Pharmacol Exp Ther; 2002 Nov; 303(2):557-62. PubMed ID: 12388636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.